Vitaspring Biomedical Co. Ltd. (VSBC): Total Assets
$14.7K
As of 2026-01-31
$14.8K
As of 2026-07-31
-73.2%
3-year compound annual growth
-40.0%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2026-01-31 | $14.7K | +2.1% | 2026-06-17, Balance as of period end |
| 2025-01-31 | $14.4K | -89.5% | 2026-06-17, Balance as of period end |
| 2024-01-31 | $137.3K | -82.1% | 2026-06-08, Balance as of period end |
| 2023-01-31 | $765.9K | -78.7% | 2026-03-12, Balance as of period end |
| 2022-01-31 | $3.60M | n/m | 2025-12-01, Balance as of period end |
| 2021-01-31 | $189.4K | n/a | 2022-05-03, Balance as of period end |
| 2020-01-31 | $0 | n/a | 2021-04-14, Balance as of period end |
| 2019-01-31 | $0 | -100.0% | 2020-06-09, Balance as of period end |
| 2018-01-31 | $1.9K | n/a | 2019-04-26, Balance as of period end |
| 2017-01-31 | $0 | n/a | 2018-05-16, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Vitaspring Biomedical Co. Ltd. (VSBC) | 2026-01-31 | $14.7K | +2.1% |
| NRC Health (NRC) | 2025-12-31 | $134.88M | +1.8% |
| Incyte Corp (INCY) | 2025-12-31 | $6.96B | +27.8% |
| Icon PLC (ICLR) | 2025-12-31 | $16.27B | -2.2% |
| Charles River Laboratories International, Inc. (CRL) | 2025-12-27 | $7.14B | -5.2% |
| MaxCyte, Inc. (MXCT) | 2025-12-31 | $202.51M | -15.4% |
| Cannabis Bioscience International Holdings, Inc. (CBIH) | 2025-05-31 | $31.9K | -44.2% |
| Iqvia Holdings Inc. (IQV) | 2025-12-31 | $29.94B | +11.3% |
| iSpecimen Inc. (ISPC) | 2025-12-31 | $9.53M | +1.9% |
Compare VSBC, NRC, INCY, ICLR side by side · Screen every company in Services-Commercial Physical & Biological Research ↗